Exelon Lobbies Against Corporate Minimum Tax
Exelon is lobbying Congress to modify the corporate alternative minimum tax (CAMT), established by the Inflation Reduction Act of 2022, to reduce costs for regulated utilities. The company has spent $4.31 million on lobbying over the past four quarters, focusing on H.R. 2872 and CAMT policy. Recent IRS guidance reduced Exelon's CAMT liability by $80 million, and the company received $235 million from Constellation due to lower tax attributes.
How this was made
The 30-second read
Why it matters
The disclosed lobbying expenses and recent IRS guidance reduce Exelon's tax burden, offering a modest earnings boost.
Market read
Regulatory tax policy news for a large utility; modest trading relevance.
What to watch
Potential future legislative changes could reverse current tax relief.
Background
Exelon is a major U.S. regulated utility facing the corporate alternative minimum tax (CAMT).
Ticker impact
Exelon disclosed increased lobbying spend and recent tax relief that lowered its CAMT liability by $80 million, affecting its cost structure.
Potential modest upside if the tax benefit translates to higher EPS.
The $80 M CAMT reduction and $235 M cash inflow are material but limited in scale; market reaction likely muted.
Market effects
Regulated utilities may see similar tax‑policy lobbying, but impact is company‑specific.
U.S. utility sector could experience slight repricing if policy changes broaden.
Limited; primarily U.S. utility and tax‑policy investors.
Counterpoint
Higher lobbying spend could be viewed as a cost drag outweighing tax benefits.
Key entities
- CompanyExelon
U.S. utility company subject to CAMT.
- LegislationH.R. 2872 (RESILIENCE Act)
Proposed bill affecting CAMT treatment for utilities.
